SCG Cell Therapy
Singapore - SingaporeBiotechnology
Focus: SCG Cell Therapy is a Singapore-based biotechnology company specializing in adoptive cell therapy, bispecific antibodies, and vaccines focused on cell therapy, infectious diseases, gene therapy, and vaccine development. The company operates at pre-clinical to early clinical stage with a lean portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About SCG Cell Therapy
AI assessmentNot HiringNo open roles listed right now. Follow SCG Cell Therapy to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
SCG101
HCCClinical Trials (1)
NCT06617000A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
Phase 1Help build intelligence for SCG Cell Therapy
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.